Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugs

21 Jul 2014

Abstract excerpt

Neuraminidase inhibitors (NAIs) oseltamivir and zanamivir are currently the only effective antiviral drugs available worldwide for the management of influenza. The potential development of resistance is continually threatening their use, rationalizing and highlighting the need for a close and sustained evaluation of virus susceptibility. This study aimed to analyze and characterize the phenotypic and genotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Influenza Virus Research Studies
Share to Protein Structure and Dynamics
Share to Respiratory viral infections research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25042157
DOI: 10.1002/jmv.23986

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Influenza A(H1N1)pdm09 resistance and cross-decreased susceptibility to oseltamivir and zanamivir antiviral drugsPMID 25042157Read ↗

Development of oseltamivir and zanamivir resistance in influenza A(H1N1)pdm09 virus, Denmark, 2014.Semantic proximity Read ↗

Neuraminidase inhibitor resistance in influenza: a clinical perspectiveSemantic proximity Read ↗

Susceptibility of Brazilian influenza A(H1N1)pdm09 viruses to neuraminidase inhibitors in the 2014-2016 seasons: Identification of strains bearing mutations associated with reduced inhibition profile.Semantic proximity Read ↗

Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023.Semantic proximity Read ↗

Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistanceSemantic proximity Read ↗

Detection and management of antiviral resistance for influenza virusesSemantic proximity Read ↗

Molecular pathway of influenza pan-neuraminidase inhibitors resistance in an immunocompromised patientSemantic proximity Read ↗

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Semantic proximity Read ↗

Global emergence of neuraminidase inhibitor-resistant influenza A(H1N1)pdm09 viruses with I223V and S247N mutations: implications for antiviral resistance monitoringSemantic proximity Read ↗

Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.Semantic proximity Read ↗

Evolutionary Characteristic of Global H1N1 Influenza A Viruses With Oseltamivir Resistance From 1918 to 2024Semantic proximity Read ↗

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.